Literature DB >> 9576927

Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.

E Mascareno1, M Dhar, M A Siddiqui.   

Abstract

The role of the peptide hormone angiotensin (AngII) in promoting myocardial hypertrophy is well documented. Our studies demonstrate that AngII uses a signaling pathway in cardiac myocytes in which the promoter of the gene encoding its prohormone, angiotensinogen, serves as the target site for activated signal transduction and activator of transcription (STAT) proteins. Gel mobility-shift assay revealed that STAT3 and STAT6 are selectively activated by AngII treatment of cardiomyocytes in culture and bind to a sequence motif (St-domain) in the angiotensinogen promoter to activate its transcription in transient transfection assay. We have also observed a dramatic increase in the St-domain binding activity of STAT proteins in the hypertrophied heart of the genetically hypertensive rat relative to that of the aged-matched normotensive strain WKY, providing a compelling argument in favor of the linkage of STAT pathway to the heart tissue autocrine AngII loop. These studies thus uncover a mechanism by which the activation of a selective set of STATs underlies mobilization of the gene activation program intrinsic to cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576927      PMCID: PMC20422          DOI: 10.1073/pnas.95.10.5590

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Differential expression of the myocyte enhancer factor 2 family of transcription factors in development: the cardiac factor BBF-1 is an early marker for cardiogenesis.

Authors:  S Goswami; P Qasba; S Ghatpande; S Carleton; A K Deshpande; M Baig; M A Siddiqui
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

2.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

3.  Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

Authors:  J Sadoshima; Y Xu; H S Slayter; S Izumo
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

4.  Molecular basis of human hypertension: role of angiotensinogen.

Authors:  X Jeunemaitre; F Soubrier; Y V Kotelevtsev; R P Lifton; C S Williams; A Charru; S C Hunt; P N Hopkins; R R Williams; J M Lalouel
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

5.  Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.

Authors:  K Shuai; C Schindler; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

6.  Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.

Authors:  T Kagoshima; J Masuda; T Sutani; Y Sakaguchi; M Tsuchihashi; S Tsuruta; M Iwano; K Dohi; Y Nakamura; N Konishi
Journal:  Blood Press Suppl       Date:  1994

7.  Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes.

Authors:  A Fukamizu; K Sugimura; E Takimoto; F Sugiyama; M S Seo; S Takahashi; T Hatae; N Kajiwara; K Yagami; K Murakami
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

8.  Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.

Authors:  D Pennica; K L King; K J Shaw; E Luis; J Rullamas; S M Luoh; W C Darbonne; D S Knutzon; R Yen; K R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

9.  Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein.

Authors:  G J Bhat; T J Thekkumkara; W G Thomas; K M Conrad; K M Baker
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  34 in total

1.  Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.

Authors:  J S Huang; J Y Guh; W C Hung; M L Yang; Y H Lai; H C Chen; L Y Chuang
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

2.  A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3.

Authors:  Koh Nakayama; Kyung-Woon Kim; Atsushi Miyajima
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

3.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

4.  Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Romer A Gonzalez-Villalobos; Julie R Ingelfinger; L Gabriel Navar; Hiroyuki Kobori
Journal:  FASEB J       Date:  2012-02-01       Impact factor: 5.191

5.  Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.

Authors:  Eduardo Mascareno; Josephine Galatioto; Inna Rozenberg; Louis Salciccioli; Haroon Kamran; Jason M Lazar; Fang Liu; Thierry Pedrazzini; M A Q Siddiqui
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

6.  Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism.

Authors:  Kristin E Claflin; Jeremy A Sandgren; Allyn M Lambertz; Benjamin J Weidemann; Nicole K Littlejohn; Colin M L Burnett; Nicole A Pearson; Donald A Morgan; Katherine N Gibson-Corley; Kamal Rahmouni; Justin L Grobe
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

7.  Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide.

Authors:  Eduardo Mascareno; Daniel Beckles; Manya Dhar-Mascareno; M A Q Siddiqui
Journal:  Vascul Pharmacol       Date:  2009-06-26       Impact factor: 5.773

8.  Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.

Authors:  Zhaoyang Hu; Ritu Kant; Marie Anand; Elizabeth C King; Trine Krogh-Madsen; David J Christini; Geoffrey W Abbott
Journal:  Circ Cardiovasc Genet       Date:  2014-01-08

Review 9.  Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.

Authors:  Jason J Gajarsa; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

10.  Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Megan S Johnson; Javad Habibi; Lakshmi Pulakat; Rukhsana Gul; Melvin R Hayden; Roger D Tilmon; Kevin C Dellsperger; Nathaniel Winer; Adam T Whaley-Connell; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.